Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
Argus Health
US Army
Queensland Health
Federal Trade Commission
Accenture
Dow
Healthtrust

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018920

« Back to Dashboard

NDA 018920 describes M.V.I. PEDIATRIC, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the M.V.I. PEDIATRIC profile page.

The generic ingredient in M.V.I. PEDIATRIC is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.
Summary for 018920
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Tradename:M.V.I. PEDIATRIC
Applicant:Hospira
Ingredient:ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e
Patents:0